FunPep Co Ltd
TSE:4881
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
FunPep Co Ltd
Tax Provision
FunPep Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
FunPep Co Ltd
TSE:4881
|
Tax Provision
¥99.7m
|
CAGR 3-Years
232%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SanBio Co Ltd
TSE:4592
|
Tax Provision
¥728.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
|
GNI Group Ltd
TSE:2160
|
Tax Provision
-¥2.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Tax Provision
¥1.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Tax Provision
-¥1.6B
|
CAGR 3-Years
41%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-1%
|
|
|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Tax Provision
-¥4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
FunPep Co Ltd
Glance View
FunPep KK engages in the research and development of pharmaceutical drugs, functional cosmetics and medical devices. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 15 full-time employees. The company went IPO on 2020-12-25. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The firm is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.
See Also
What is FunPep Co Ltd's Tax Provision?
Tax Provision
99.7m
JPY
Based on the financial report for Dec 31, 2025, FunPep Co Ltd's Tax Provision amounts to 99.7m JPY.
What is FunPep Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 3Y
232%
Over the last year, the Tax Provision growth was 1 316%. The average annual Tax Provision growth rates for FunPep Co Ltd have been 232% over the past three years .
